{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:54:19Z","timestamp":1781769259451,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010166","name":"Xiamen City Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023J01013"],"award-info":[{"award-number":["2023J01013"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016808","name":"Natural Science Foundation of Xiamen Municipality","doi-asserted-by":"publisher","award":["HAXM-MEC-20250814-063-01"],"award-info":[{"award-number":["HAXM-MEC-20250814-063-01"]}],"id":[{"id":"10.13039\/100016808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016808","name":"Natural Science Foundation of Xiamen Municipality","doi-asserted-by":"publisher","award":["3502720244ZD1156"],"award-info":[{"award-number":["3502720244ZD1156"]}],"id":[{"id":"10.13039\/100016808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016808","name":"Natural Science Foundation of Xiamen Municipality","doi-asserted-by":"publisher","award":["3502Z20227118"],"award-info":[{"award-number":["3502Z20227118"]}],"id":[{"id":"10.13039\/100016808","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.labinv.2026.106074","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T17:15:58Z","timestamp":1768929358000},"page":"106074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clonal Progression of a DNA Polymerase Epsilon\u2013Mutant Endometrial Cancer With Immune Evasion Characteristics and Metastasis"],"prefix":"10.1016","volume":"106","author":[{"given":"Ruirui","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4086-5076","authenticated-orcid":false,"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.labinv.2026.106074_bib1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/CAD.0000000000001596","article-title":"Experience with pembrolizumab in a renal transplant patient with advanced lung cancer: a case report and review","volume":"35","author":"Fern\u00e1ndez Madrigal","year":"2024","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.labinv.2026.106074_bib2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.6004\/jnccn.2019.7310","article-title":"Preexisting autoimmune disease: implications for immune checkpoint inhibitor therapy in solid tumors","volume":"17","author":"Kennedy","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"14","key":"10.1016\/j.labinv.2026.106074_bib3","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/cncr.33516","article-title":"Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: an individual patient data meta-analysis","volume":"127","author":"McAlpine","year":"2021","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.labinv.2026.106074_bib4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41571-024-00934-7","article-title":"Translating biological insights into improved management of endometrial cancer","volume":"21","author":"How","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.labinv.2026.106074_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/tcmj.tcmj_120_24","article-title":"The prognostic implication of polymerase epsilon-mutated endometrial cancer","volume":"37","author":"Wang","year":"2024","journal-title":"Tzu Chi Med J"},{"issue":"1","key":"10.1016\/j.labinv.2026.106074_bib6","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.labinv.2026.106074_bib7","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/modpathol.2015.43","article-title":"Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative","volume":"28","author":"Stelloo","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2026.106074_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.25259\/Cytojournal_37_2024","article-title":"Molecular classification of endometrial cancer: impact on adjuvant treatment planning","volume":"21","author":"Zouzoulas","year":"2024","journal-title":"Cytojournal"},{"key":"10.1016\/j.labinv.2026.106074_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ygyno.2025.03.006","article-title":"The genomic landscape of distant metastatic endometrial cancer","volume":"195","author":"Zammarrelli","year":"2025","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.labinv.2026.106074_bib10","series-title":"World Health Organization Classification of Tumours. Female Genital Tumours","year":"2020"},{"issue":"3","key":"10.1016\/j.labinv.2026.106074_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.5372","article-title":"Interpretation of somatic POLE mutations in endometrial carcinoma","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Pathol"},{"issue":"14","key":"10.1016\/j.labinv.2026.106074_bib12","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1158\/1078-0432.CCR-15-0057","article-title":"POLE proofreading mutations elicit an antitumor immune response in endometrial cancer","volume":"21","author":"Van Gool","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.labinv.2026.106074_bib13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/ijgc-2020-002256","article-title":"p53abn endometrial cancer: understanding the most aggressive endometrial cancers in the era of molecular classification","volume":"31","author":"Jamieson","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.labinv.2026.106074_bib14","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s41379-022-01102-x","article-title":"p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial","volume":"35","author":"Vermij","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2026.106074_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.labinv.2026.106074_bib16","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/ajt.15811","article-title":"Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: a systematic review","volume":"20","author":"D\u2019Izarny-Gargas","year":"2020","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.labinv.2026.106074_bib17","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41581-018-0022-6","article-title":"Cancer in kidney transplant recipients","volume":"14","author":"Au","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.labinv.2026.106074_bib18","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1681\/ASN.2015040373","article-title":"Variation in cancer incidence among patients with ESRD during kidney function and nonfunction intervals","volume":"27","author":"Yanik","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106074_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/ajt.13978","article-title":"Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines","volume":"17","author":"Acuna","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.labinv.2026.106074_bib20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12882-017-0553-2","article-title":"Renal association clinical practice guideline in post-operative care in the kidney transplant recipient","volume":"18","author":"Baker","year":"2017","journal-title":"BMC Nephrol"},{"issue":"6","key":"10.1016\/j.labinv.2026.106074_bib21","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/j.1525-1438.2008.01200.x","article-title":"Chemotherapy for gynecological malignancies in organ transplantation patients: report of two cases","volume":"18","author":"Tao","year":"2008","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.labinv.2026.106074_bib22","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/jog.13337","article-title":"Total laparoscopic hysterectomy for endometrial cancer in a renal transplantation patient receiving peritoneal dialysis: case report and literature review","volume":"43","author":"Kakuda","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"10.1016\/j.labinv.2026.106074_bib23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.transproceed.2021.12.021","article-title":"Endometrial cancer after pancreas-after-kidney transplantation: a case report and review of the literature","volume":"54","author":"Kobayashi","year":"2022","journal-title":"Transplant Proc"},{"key":"10.1016\/j.labinv.2026.106074_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ygyno.2025.03.038","article-title":"Genetic predictors of unexpected recurrence in low-risk endometrial cancer: a comprehensive genomic analysis reveals FGFR2 as a risk factor and a rare fatal POLE-mutated recurrence","volume":"196","author":"Mett\u00e4l\u00e4","year":"2025","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.labinv.2026.106074_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.transproceed.2005.12.007","article-title":"High rate of endometrial hyperplasia in renal transplanted women","volume":"38","author":"Bobrowska","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.labinv.2026.106074_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0025-6196(25)07829-2","article-title":"Endometrioid carcinoma of the uterus and ovaries associated with immunosuppressive therapy and anticoagulation: report of a case","volume":"47","author":"Kim","year":"1972","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.labinv.2026.106074_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004879","article-title":"Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study","volume":"10","author":"Shui","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.labinv.2026.106074_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae061","article-title":"Fine-tuning tumor- and allo-immunity: advances in the use of immune checkpoint inhibitors in kidney transplant recipients","volume":"17","author":"Van Meerhaeghe","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.labinv.2026.106074_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1474663","article-title":"Case report: partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient","volume":"15","author":"Ormston","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.labinv.2026.106074_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013294","article-title":"Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo","volume":"5","author":"Morteau","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.labinv.2026.106074_bib32","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1681\/ASN.2015030250","article-title":"CD8+ immunosenescence predicts post-transplant cutaneous squamous cell carcinoma in high-risk patients","volume":"27","author":"Bottomley","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.labinv.2026.106074_bib33","first-page":"279","article-title":"Application of WHO molecular classification in endometrial cancer (2020) and its clinicopathological significance","volume":"40","author":"Liyu","year":"2024","journal-title":"Chinese J Clin Exp Pathol"},{"issue":"6","key":"10.1016\/j.labinv.2026.106074_bib34","first-page":"580","article-title":"Comparative study of next generation sequencing and immunohistochemistry on molecular classification of endometrial carcinoma","volume":"52","author":"Chen","year":"2023","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"7447","key":"10.1016\/j.labinv.2026.106074_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683726000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683726000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:26:39Z","timestamp":1781767599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683726000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0023683726000048"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106074","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonal Progression of a DNA Polymerase Epsilon\u2013Mutant Endometrial Cancer With Immune Evasion Characteristics and Metastasis","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"106074"}}